Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Publication year range
1.
Cleft Palate Craniofac J ; 60(7): 810-822, 2023 Jul.
Article in English | MEDLINE | ID: mdl-35360961

ABSTRACT

OBJECT: To identify the perception of barriers to the comprehensive management of cleft lip and palate (CLP) by parents/caregivers of Colombian children with this condition. SETTING AND SAMPLE POPULATION: Fifty parents/caregivers of children with CLP under 12 years attending a center specialized in the management of craniofacial congenital conditions in Bogota, Colombia. MATERIALS AND METHODS: This study consisted of 2 phases: a quantitative phase (descriptive cross-sectional) and a qualitative phase (focus group [FG]). Chi-square and Fisher exact tests were used to analyze the association variables. The barriers and alternative ways to overcome barriers were analyzed in the FG. RESULTS: Comprehensive management was mostly defined as access to multiple treatments (54%), and this concept was expanded in the FG toward understanding CLP at all levels. Monoparental families spend their income on treatments (29%) than nuclear families (0%) (P = .001). All parents with high education levels were familiar with healthcare centers specialized in CLP as opposed to 66.7% of parents with basic primary education (P < .05). Regarding the timeliness of appointments, 12.2% of parents earning between 1 and 2 minimum wages reported some kind of difficulty, whereas those earning less than one minimum wage reported difficulties in 66.7% of cases (P = .046). CONCLUSIONS: All participants reported barriers, which increased or decreased depending on their socioeconomic status. The FG allowed the discussion of alternatives to overcome barriers, such as structural, solidarity, and self-management actions.


Subject(s)
Cleft Lip , Cleft Palate , Child , Humans , Cleft Lip/surgery , Colombia , Cleft Palate/surgery , Cross-Sectional Studies , Parents , Perception
2.
Rev. méd. IMSS ; 32(1): 23-6, ene.-feb. 1994. tab
Article in Spanish | LILACS | ID: lil-176859

ABSTRACT

El objetivo es demostrar la utilidad de la octreotida en la diarrea por cólera. Se estudiaron 60 pacientes con cólera, a 30 se les aplicó inicialmente 200 mcg vía subcutánea de octreotida, posteriormente 100 mcg cada seis horas durante 72 horas, todos recibieron tetraciclina 500 mg cada seis horas por siete días y soluciones electrolíticas. En el grupo tratado con octreotida (grupo I) hubo una disminución estadísticamente significativa p<0.05 en el número de evacuaciones y en la cantidad de líquido perdido por heces, a las 24 horas (X=5.6ñ1.0) (X=3370ñ600 mL) y 48 horas (X=4.8ñ1.2) (X=2100ñ376 mL); comparativamente al grupo tratado sin octreotida (grupo II) el cual mostró un número de evacuaciones de X=11.5ñ2.4, y una pérdida de líquidos por heces de X=7613ñ768 a las 24 horas y X=8.8ñ1.5 con un débito de líquidos de X=4425ñ889 mL a las 48 horas. La administración de octreotida, tetraciclina y soluciones intravenosas son eficaces en el control de la diarrea por cólera


Subject(s)
Adolescent , Adult , Middle Aged , Humans , Tetracycline/therapeutic use , Vibrio cholerae/pathogenicity , Diarrhea/therapy , Gram-Negative Bacteria/pathogenicity , Cholera/therapy , Octreotide/pharmacokinetics , Octreotide/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...